PARTICIPATION AGREEMENT
THIS AGREEMENT, made and entered into as of the 1st day of June, 2010 by and among Pacific
Life & Annuity Company (hereinafter the “Company”), a life insurance company organized under the
laws of Arizona, on its own behalf and on behalf of each separate account of the Company set forth
on Schedule B hereto as may be amended from time to time (each such account hereinafter referred to
as the “Account”), and ROYCE CAPITAL FUND (hereinafter the “Fund”), a Delaware business trust, and
ROYCE FUND SERVICES, INC., a New York corporation (the “Distributor”).
WHEREAS, the Fund engages in business as an open-end management investment company and is
available to act as (i) the investment vehicle for separate accounts established by insurance
companies for individual and group life insurance policies and annuity contracts with variable
accumulation and/or pay-out provisions (hereinafter referred to individually and/or collectively as
“Variable Insurance Products”) and (ii) the investment vehicle for certain qualified pension and
retirement plans (hereinafter “Qualified Plans”); and
WHEREAS, insurance companies desiring to utilize the Fund as an investment vehicle under their
Variable Insurance Products are required to enter into a participation agreement with the Fund and
the Distributor (the “Participating Insurance Companies”); and
WHEREAS, shares of the Fund are divided into several series of shares, each representing the
interest in a particular managed portfolio of securities and other assets, any one or more of which
may be made available for Variable Insurance Products of Participating Insurance Companies; and
WHEREAS, the Fund intends to offer shares of the series set forth on Schedule A (each such
series hereinafter referred to as a “Portfolio”), as may be amended from time to time by mutual
agreement of the parties hereto, under this Agreement to the Accounts of the Company; and
WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission, dated
July 24, 1996 (File No. 812-9988), granting Participating Insurance Companies and Variable
Insurance Product separate accounts exemptions from the provisions of Sections 9(a), 13(a), 15(a),
and 15(b) of the Investment Company Act of 1940, as amended (hereinafter the “1940 Act”), and Rules
6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Fund to
be sold to and held by Variable Insurance Products separate accounts of both affiliated and
unaffiliated life insurance companies and Qualified Plans (hereinafter the “Shared Funding
Exemptive Order”); and
WHEREAS, the Fund is registered as an open-end management investment company under the 1940
Act and its shares are registered under the Securities Act of 1933, as amended (hereinafter the
“1933 Act”); and
WHEREAS, the Distributor is registered as a broker-dealer with the SEC under the Securities
Exchange Act of 1934, as amended (hereinafter the “1934 Act”), and is a member in good standing
of the Financial Industry Regulatory Authority (“FINRA”); and
WHEREAS, the Distributor is the principal underwriter of the Portfolios of the Fund; and
WHEREAS, the Company has registered or will register certain Variable Insurance Products under
the 1933 Act; and
WHEREAS, each Account is a duly organized, validly existing segregated asset account,
established by resolution or under authority of the Board of Directors of the Company, on the date
shown for such Account on Schedule B hereto, to set aside and invest assets attributable to the
aforesaid Variable Insurance Products; and
WHEREAS, the Company has registered or will register each Account as a unit investment trust
under the 1940 Act; and
WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company
intends to purchase shares in the Portfolios on behalf of each Account to fund certain of the
aforesaid Variable Insurance Products;
NOW, THEREFORE, in consideration of their mutual promises, the Company and the Fund agree as
follows:
ARTICLE I. Fund Shares
1.1. The Fund agrees to make available for purchase by the Company shares of the Portfolios
set forth on Schedule A and shall execute orders placed for each Account on a daily basis at the
net asset value next computed after receipt by the Fund or its designee of such order. For
purposes of this Section 1.1, the Company shall be the designee of the Fund for receipt of such
orders from each Account and receipt by such designee of orders prior to the close of regular
trading on the New York Stock Exchange (generally 4:00 p.m. Eastern time) shall constitute receipt
by the Fund; provided that the Fund receives notice of such order by 10:00 a.m. Eastern time on the
next following Business Day. Notwithstanding the foregoing, the Company shall use its best efforts
to provide the Fund with notice of such orders by 9:00 a.m. Eastern time on the next following
Business Day. “Business Day” shall mean any day on which the New York Stock Exchange is open for
trading and on which the Fund calculates the net asset value pursuant to the rules of the SEC, as
set forth in the Fund’s Prospectus and Statement of Additional Information. Notwithstanding the
foregoing, the Board of Trustees of the Fund (hereinafter the “Board”) may refuse to permit the
Fund to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares
of any Portfolio, if such action is required by law or by regulatory authorities having
jurisdiction or is, in the sole discretion of the Board acting in good faith and in light of their
fiduciary duties under federal and any applicable state laws, necessary in the best interests of
the shareholders of such Portfolio.
1.2. The Fund agrees that shares of the Fund will be sold only to Participating Insurance
Companies and their Variable Insurance Products and to certain Qualified Plans. No shares of
any
Portfolio will be sold to the general public.
1.3. The Fund will not make its shares available for purchase by any insurance company or
separate account unless an agreement containing provisions substantially the same as Sections 2.4,
2.9, 3.4 and Article VII of this Agreement is in effect to govern such sales.
1.4. The Fund agrees to redeem for cash, on the Company’s request, any full or fractional
shares of the Fund held by the Company, executing such requests on a daily basis at the net asset
value next computed after receipt by the Fund or its designee of the request for redemption. For
purposes of this Section 1.4, the Company shall be the designee of the Fund for receipt of requests
for redemption from each Account and receipt by such designee shall constitute receipt by the Fund;
provided that the Fund receives notice of such request for redemption on the next following
Business Day in accordance with the timing rules described in Section 1.1.
1.5. The Company agrees that purchases and redemptions of Portfolio shares offered by the
then current prospectus of the Fund shall be made in accordance with the provisions of such
prospectus. The Accounts of the Company, under which amounts may be invested in the Fund, are
listed on Schedule B attached hereto and incorporated herein by reference, as such Schedule B may
be amended from time to time by mutual written agreement of all of the parties hereto.
1.6. The Company will place separate orders to purchase or redeem shares of each Portfolio.
Each order shall describe the net amount of shares and dollar amount of each Portfolio to be
purchased or redeemed. In the event of net purchases, the Company shall pay for Portfolio shares
on the next Business Day after an order to purchase Portfolio shares is made in accordance with the
provisions of Section 1.1 hereof. Payment shall be in federal funds transmitted by wire. In the
event of net redemptions, the Portfolio shall use its best efforts to pay the redemption proceeds
in federal funds transmitted by wire on the next Business Day, in any event redemption proceeds
shall be wired to the Company within three Business Days or such longer period permitted by the
1940 Act, after an order to redeem a Portfolio’s shares is made in accordance with the provision of
Section 1.4 hereof. Notwithstanding the foregoing, if the payment of redemption proceeds on the
next Business Day would require the Portfolio to dispose of securities or otherwise incur
substantial additional costs, and if the Portfolio has determined to settle redemption transactions
for all shareholders on a delayed basis, it reserves the right to suspend the right of redemption
or postpone the date of payment or satisfaction upon redemption consistent with Section 22(e) of
the 1940 Act and the Portfolio shall notify in writing the person designated by the Company as the
recipient for such notice of such delay promptly.
1.7. Issuance and transfer of the Fund’s shares will be by book entry only. Stock
certificates will not be issued to the Company or any Account. Shares ordered from the Fund will
be recorded in an appropriate title for each Account or the appropriate subaccount of each Account.
1.8. The Fund shall make the dividends or capital gain distributions per share payable on the
Fund’s shares available to the Company as soon as reasonably practical after the dividends or
capital gains are declared (normally by 6:30 p.m. Eastern time) and shall use its best efforts to
furnish same day notice by 7:00 p.m. Eastern time (by wire or telephone, followed by written
confirmation) to the
Company of any dividends or capital gain distributions per share payable on
the Fund’s shares. The Company hereby elects to receive all such dividends and capital gain
distributions as are payable on the Portfolio shares in additional shares of that Portfolio. The
Company reserves the right to revoke this election and to receive all such dividends and capital
gain distributions in cash. The Fund shall notify the Company of the number of shares so issued as
payment of such dividends and distributions.
1.9. The Fund shall make the net asset value per share for each Portfolio available to the
Company on a daily basis as soon as reasonably practical after the net asset value per share is
calculated (normally by 6:30 p.m. Eastern time) and shall use its best efforts to make such net
asset value per share available by 7:00 p.m. Eastern time. In the event that the Fund is unable to
meet the 7:00 p.m. time stated immediately above, then the Fund shall provide the Company with
additional time to notify the Fund of purchase or redemption orders pursuant to Sections 1.1 and
1.4, respectively, above. Such additional time shall be equal to the additional time that the Fund
takes to make the net asset values available to the Company; provided, however, that notification
must be made by 10:15 a.m. Eastern time on the Business Day such order is to be executed regardless
of when the net asset value is made available. If the Fund provides the Company with materially
incorrect share net asset value information, the Separate Account(s) shall be entitled to any
adjustment to the number of shares purchased or redeemed necessary to make the Separate Account(s)
whole. Any material error in the calculation of the net asset value per share, dividend or capital
gain information shall be reported promptly upon discovery to the Company. The Distributor shall be
liable for the reasonable administrative costs incurred by the Company in relation to the
correction of any material error, provided such error is attributable to the Fund or the
Distributor. Administrative costs shall include reasonable allocation of staff time, costs of
outside service providers, printing and postage. Non-material errors will be corrected in the next
Business Day’s net asset value per share.
1.10 The Fund agrees that, so long as this Agreement remains in effect, it will not purge or
close any accounts it establishes to effect purchases and redemptions of its shares by the
Company’s Separate Accounts.
ARTICLE II. Representations and Warranties
2.1. The Company represents and warrants that the interests of the Accounts (the “Contracts”)
are or will be registered and will maintain the registration under the 1933 Act and the regulations
thereunder to the extent required by the 1933 Act; that the Contracts will be issued in compliance
in all material respects with all applicable federal and state laws and regulations. The Company
further represents and warrants that it is an insurance company duly organized and in good standing
under applicable law and that it has legally and validly established each Account prior to
any issuance or sale thereof as a segregated asset account under the Arizona Insurance Law and
the regulations thereunder and has registered or, prior to any issuance or sale of the Contracts,
will register and will maintain the registration of each Account as a unit investment trust in
accordance
with and to the extent required by the provisions of the 1940 Act and the regulations
thereunder to serve as a segregated investment account for the Contracts. The Company shall amend
its registration statement for its contracts under the 1933 Act and the 1940 Act from time to time
as required in order to effect the continuous offering of its Contracts.
2.2. The Fund represents and warrants that Fund shares sold pursuant to this Agreement shall
be registered under the 1933 Act and the regulations thereunder to the extent required by the 1933
Act, duly authorized for issuance in accordance with the laws of the State of Delaware and sold in
compliance with all applicable federal and state securities laws and regulations and that the Fund
is and shall remain registered under the 1940 Act and the regulations thereunder to the extent
required by the 0000 Xxx. The Fund shall amend the registration statement for its shares under the
1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering
of its shares. The Fund shall register and qualify the shares for sale in accordance with the laws
of the various states only if and to the extent deemed advisable by the Fund.
2.3 The Fund and the Distributor represent that the Fund is currently qualified as a Regulated
Investment Company under Subchapter M of the Internal Revenue Code of 1986, as amended (the
“Code”), and that the Fund will make every effort to maintain such qualification (under Subchapter
M or any successor or similar provision) and that the Fund or its designee will notify the Company
immediately upon having a reasonable basis for believing that a Portfolio has ceased to so qualify
or that a Portfolio might not so qualify in the future.
2.4. The Company represents that each Account is and will continue to be a “segregated
account” under applicable provisions of the Code and that each Contract is and will be treated as a
“variable contract” under applicable provisions of the Code and that it will make every effort to
maintain such treatments and that it will notify the Fund immediately upon having a reasonable
basis for believing that the Account or Contract has ceased to be so treated or that they might not
be so treated in the future.
2.5. The Fund represents that to the extent it decides to finance distribution expenses
pursuant to Rule 12b-1 under the 1940 Act, the Fund undertakes to have a board of trustees, a
majority of whom are not interested persons of the Fund, formulate and approve any plan under Rule
12b-1 to finance distribution expenses in accordance with the 1940 Act.
2.6. The Fund makes no representation as to whether any aspect of its operations (including,
but not limited to, fees and expenses and investment policies) complies with the insurance laws or
regulations of the various states.
2.7. The Fund and the Distributor represent that the Fund is lawfully organized and validly
existing under the laws of Delaware and that the Fund does and will comply in all material respects
with the 1940 Act.
2.8. The Distributor represents and warrants that it is and shall remain duly registered in
all material respects under all applicable federal securities laws and that it will perform its
obligations for the Fund and the Company in compliance in all material respects with the laws and
regulations of
its state of domicile and any applicable state and federal securities laws and
regulations.
2.9. The Company represents and warrants that all of its trustees, officers, employees,
investment adviser, and other individuals/entities dealing with the money and/or securities of the
Fund are covered by a blanket fidelity bond or similar coverage, in an amount equal to the greater
of $5 million or any amount required by applicable federal or state law or regulation. The
aforesaid includes coverage for larceny and embezzlement is issued by a reputable bonding company.
The Company agrees to make all reasonable efforts to see that this bond or another bond containing
these provisions is always in effect, and agrees to notify the Fund in the event that such coverage
no longer applies.
2.10. The Company represents and warrants that it will adhere to the Company’s policy
intended to discourage shareholders from trading that could be detrimental to long-term
shareholders of the Fund (the “Policy”), as set forth in the Company’s current prospectus (“Company
Prospectus”). The aforesaid includes among other things, the monitoring of shareholder/participant
trading activity and the restriction of shareholder/participant trading privileges at the
sub-account level if warranted by the Policy.
2.11. The Company represents and warrants that it will adhere to all applicable anti-money
laundering rules and regulations in fulfilling its obligations under this Agreement.
2.12. The Company, Fund and Distributor agree that all non-public records, information, and
data relating to the business of the other (including customer names and information and portfolio
holdings information) that are exchanged or negotiated pursuant to this Agreement or in carrying
out this Agreement shall remain confidential, and shall not be voluntarily disclosed by either
party without the prior written consent of the other party, except as may be required by law or by
such party to carry out this Agreement or an order of an court, governmental agency or regulatory
body.
ARTICLE III. Prospectuses, Reports to Shareholders and Proxy Statements; Voting
3.1(a) The Fund or its designee shall provide the Company with as many printed copies of the
Fund Prospectus as the Company may reasonably request. If requested by the Company, in addition to
providing printed copies of the Fund Prospectus, the Fund shall provide camera-ready film or
computer diskettes containing the Fund Prospectus, or shall provide the same electronically in .pdf
format, and such other assistance as is reasonably necessary in order for the Company once each
year (or more frequently if the Fund Prospectus is amended during the year) to have the prospectus
for the Contracts (the “Contract Prospectus”) and the Fund Prospectus printed together in one
document or separately. The Company may elect to print the Fund Prospectus in combination with
other fund companies’ prospectuses. For purposes hereof, any combined prospectus including the Fund
Prospectus along with the Contract Prospectus or prospectus of other fund companies shall be
referred to as a “Combined Prospectus.” For purposes hereof, the term “Fund Portion of the
Combined Prospectus” shall refer to the percentage of the number of Fund Prospectus pages in the
Combined Prospectus in relation to the total number of pages of the Combined Prospectus.
3.1(b) The Fund shall provide the Company with as many printed copies of the Fund’s current
statement of additional information (the “Fund SAI”) as the Company may reasonably request. If
requested by the Company in addition to providing printed copies of the Fund SAI, the Fund shall
provide camera-ready film or computer diskettes containing the Fund SAI, or shall provide the same
electronically in .pdf format, and such other assistance as is reasonably necessary in order for
the Company once each year (or more frequently if the Fund SAI is amended during the year) to have
the statement of additional information for the Contracts (the “Contract SAI”) and the Fund SAI
printed together or separately. The Company may also elect to print the Fund SAI in combination
with other fund companies’ statements of additional information. For purposes hereof, any combined
statement of additional information including the Fund SAI along with the Contract SAI or statement
of additional information of other fund companies shall be referred to as a “Combined SAI.” For
purposes hereof, the term “Fund Portion of the Combined SAI” shall refer to the percentage of the
number of Fund SAI pages in the Combined SAI in relation to the total number of pages of the
Combined SAI.
3.1(c) The Fund shall provide the Company with as many printed copies of the Fund’s annual
report and semi-annual report (collectively, the “Fund Reports”) as the Company may reasonably
request. If requested by the Company in lieu of providing printed copies of the Fund Reports, the
Fund shall provide camera-ready film or computer diskettes containing the Fund’s Reports, or shall
provide the same electronically in .pdf format, and such other assistance as is reasonably
necessary in order for the Company once each year to have the annual report and semi-annual report
for the Contracts (collectively, the “Contract Reports”) and the Fund Reports printed together or
separately. The Company may also elect to print the Fund Reports in combination with other fund
companies’ annual reports and semi-annual reports. For purposes hereof, any combined annual
reports and semi-annual reports including the Fund Reports along with the Contract Reports or
annual reports and semi-annual reports of other fund companies shall be referred to as “Combined
Reports.” For purposes hereof, the term “Fund Portion of the Combined Reports” shall refer to the
percentage of the number of Fund Reports pages in the Combined Reports in relation to the total
number or pages of the Combined Reports.
3.2 Expenses
3.2(a) Expenses Borne by Company. Except as otherwise provided in this Section 3.2.,
all expenses of preparing, setting in type and printing and distributing (i) Contract Prospectuses,
Fund Prospectuses, and Combined Prospectuses; (ii) Fund SAIs, Contract SAIs, and Combined SAIs;
(iii) Fund Reports, Contract Reports, and Combined Reports, and (iv) Contract proxy material that
the Company may require in sufficient quantity to be sent to Contract owners, annuitants, or
participants under Contracts (collectively, the “Participants”), shall be the expense of the
Company.
3.2(b) Expenses Borne by Fund
Fund Prospectuses
With respect to existing Participants, the Fund shall pay the cost of setting in type and
printing Fund Prospectuses made available by the Company to such existing Participants in order to
update disclosure as required by the 1933 Act and/or the 1940 Act. With respect to existing
Participants, in the event the Company elects to prepare a Combined Prospectus, the Fund shall pay
the cost of setting in type and printing the Fund Portion of the Combined Prospectus made available
by the Company to its existing Participants in order to update disclosure as required by the 1933
Act and/or the 1940 Act. In such event, the Fund shall bear the cost of typesetting to provide the
Fund Prospectus to the Company in the format in which the Fund is accustomed to formatting
prospectus. Notwithstanding the foregoing, in no event shall the Fund pay for any such costs that
exceed by more than five (5) percent what the Fund would have paid to print such documents. The
Fund shall not pay any costs of typesetting and printing the Fund Prospectus (or Combined
Prospectus, if applicable) to prospective Participants.
Fund SAIs, Fund Reports and Proxy Material
With respect to existing Participants, the Fund shall pay the cost of setting in type and
printing Fund SAIs, Fund Reports and Fund proxy material made available by the Company to its
existing Participants. With respect to existing Participants, in the event the Company elects to
prepare a Combined SAI or Combined Reports, the Fund shall pay the cost of setting in type and
printing the Fund Portion of the Combined SAI or Combined Reports, respectively, made available by
the Company to its existing Participants. In such event, the Fund shall bear the cost of
typesetting to provide the Fund SAI or Fund Reports to the Company in the format in which the Fund
is accustomed to formatting statements of additional information and annual and semi-annual
reports. Notwithstanding the foregoing, in no event shall the Fund pay for any such costs that
exceed by more than five (5) percent what the Fund would have paid to print such documents.
The Company agrees to provide the Fund or its designee with such information as may be
reasonably requested by the Fund to assure that the Fund’s expenses do not include the cost of
typesetting, printing or distributing any of the foregoing documents other than as described above.
3.3. The Fund SAI shall be obtainable from the Fund, the Company or such other person as the
Fund may designate.
3.4. If and to the extent required by law the Fund shall distribute all proxy material
furnished by the Fund to Participants to whom voting privileges are required to be extended and
shall:
(i) solicit voting instructions from Participants;
(ii) vote the Fund shares in accordance with instructions received from
Participants; and
(iii) vote Fund shares for which no instructions have been received in
the same proportion as Fund shares of such Portfolio for which instructions
have been received,
so long as and to the extent that the SEC continues to interpret the 1940 Act to require
pass-through voting privileges for variable contract owners. The Company reserves the right to
vote Fund shares
held in any segregated asset account in its own right, to the extent permitted by
law. The Fund and the Company shall follow the procedures, and shall have the corresponding
responsibilities, for the handling of proxy and voting instruction solicitations, as set forth in
Schedule C attached hereto and incorporated herein by reference. Participating Insurance Companies
shall be responsible for ensuring that each of their separate accounts participating in the Fund
calculates voting privileges in a manner consistent with the standards set forth on Schedule C,
which standards will also be provided to the other Participating Insurance Companies.
3.5. The Fund will comply with all provisions of the 1940 Act requiring voting by
shareholders, and in particular the Fund will either provide for annual meetings (except insofar as
the Securities and Exchange Commission may interpret Section 16 not to require such meetings) or
comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in
Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b).
Further, the Fund will act in accordance with the Securities and Exchange Commission’s
interpretation of the requirements of Section 16(a) with respect to periodic elections of directors
and with whatever rules the Commission may promulgate with respect thereto.
ARTICLE IV. Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to the Fund or its designee,
each piece of sales literature or other promotional material prepared by the Company or any person
contracting with the Company in which the Fund or the Distributor is named, at least ten Business
Days prior to its use. No such material shall be used if the Fund, the Distributor, or their
designee reasonably objects to such use within five Business Days after receipt of such material.
4.2. Neither the Company nor any person contracting with the Company shall give any
information or make any representations or statements on behalf of the Fund or concerning the Fund
in connection with the sale of the Contracts other than the information or representations
contained in the registration statement or the Fund Prospectus, as such registration statement or
Fund Prospectus may be amended or supplemented from time to time, or in reports or proxy statements
for the Fund, or in sales literature or other promotional material approved by the Fund or its
designee, except with the written permission of the Fund.
4.3. The Fund or its designee shall furnish, or shall cause to be furnished, to the Company
or its designee, each piece of sales literature or other promotional material prepared by the Fund
in which the Company or its Account(s) are named at least ten Business Days prior to its use. No
such material shall be used if the Company or its designee reasonably objects to such use within
five Business Days after receipt of such material.
4.4. Neither the Fund nor the Distributor shall give any information or make any
representations on behalf of the Company or concerning the Company, each Account, or the Contracts,
other than the information or representations contained in a registration statement or prospectus
for the Contracts, as such registration statement and prospectus may be amended or supplemented
from time to time, or in published reports or solicitations for voting instructions for
each
Account which are in the public domain or approved by the Company for distribution to Participants,
or in sales literature or other promotional material approved by the Company or its designee,
except with the written permission of the Company.
4.5. The Fund will provide to the Company at least one complete copy of all registration
statements, prospectuses, statements of additional information, reports, proxy statements, sales
literature and other promotional materials, applications for exemptions, requests for no-action
letters, and all amendments to any of the above, that relate to the Fund or its shares,
contemporaneously with the filing of such document with the SEC or other regulatory authorities.
4.6. Upon request, the Company will provide to the Fund at least one complete copy of all
registration statements, prospectuses, statements of additional information, reports, solicitations
for voting instructions, sales literature and other promotional materials, applications for
exemptions, requests for no action letters, and all amendments to any of the above, that relate to
the investment in an Account or Contract contemporaneously with the filing of such document with
the SEC or other regulatory authorities.
4.7. For purposes of this Article IV, the phrase “sales literature or other promotional
material” includes, but is not limited to, any of the following: advertisements (such as material
published, or designed for use in, a newspaper, magazine, or other periodical, radio, television,
telephone or tape recording, videotape display, signs or billboards, motion pictures, or other
public media), sales literature (i.e., any written communication distributed or made
generally available to customers or the public, including brochures, circulars, research reports,
market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales
literature, or published article), educational or training materials or other communications
distributed or made generally available to some or all agents or employees, and registration
statements, prospectuses, statements of additional information, shareholder reports, and proxy
materials.
ARTICLE V. [Reserved]
ARTICLE VI. Diversification
6.1. The Fund represents, that it and each Portfolio will use its best efforts at all times
to comply with Section 817(h) of the Code and Treasury Regulation 1.817-5, relating to the
diversification requirements for variable annuity, endowment, or life insurance contracts and
any amendments or other modifications to such Section or Regulations. In the event a Portfolio
ceases to so qualify, the Fund will take all reasonable steps (a) to notify the Company of such
breach and (b) to adequately diversify the Portfolio so as to achieve compliance within the grace
period afforded by Regulation 817-5.
ARTICLE VII. Potential Conflicts
7.1. The Board will monitor the Fund for the existence of any material irreconcilable
conflict between the interests of the contract owners of all separate accounts investing in the
Fund. An irreconcilable material conflict may arise for a variety of reasons, including: (a) an
action by any state insurance regulatory authority; (b) a change in applicable federal or state
insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling,
no-action or interpretative letter, or any similar action by insurance, tax, or securities
regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d)
the manner in which the investments of any Portfolio are being managed; (e) a difference in voting
instructions given by variable annuity contract owners and variable life insurance contract owners;
or (f) a decision by a Participating Insurance Company to disregard the voting instructions of
Contract owners. The Board shall promptly inform the Company if it determines that an
irreconcilable material conflict exists and the implications thereof.
7.2. The Company will report any potential or existing material irreconcilable conflicts of
which it is aware to the Board. The Company will assist the Board in carrying out its
responsibilities under the Shared Funding Exemptive Order, by providing the Board with all
information reasonably necessary for the Board to consider any issues raised. This includes, but
is not limited to, an obligation by the Company to inform the Board whenever contract owner voting
instructions are disregarded.
7.3. If it is determined by a majority of the Board, or a majority of its disinterested
directors, that a material irreconcilable conflict exists, the Company and other Participating
Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined
by a majority of the disinterested trustees), take whatever steps are necessary to remedy or
eliminate the irreconcilable material conflict, up to and including: (1) withdrawing the assets
allocable to some or all of the Separate Accounts from the Fund or any Portfolio and reinvesting
such assets in a different investment medium, including (but not limited to) another Portfolio of
the Fund, or submitting the question whether such segregation should be implemented to a vote of
all affected Contract owners and, as appropriate, segregating the assets of any appropriate group
(i.e., annuity contract owners, life insurance policy owners, or variable Contract owners
of one or more Participating Insurance Companies) that votes in favor of such segregation, or
offering to the affected Contract owners the option of making such a change; and (2) establishing a
new registered management investment company or managed separate account. No charge or penalty
will be imposed as a result of such withdrawal. The Company agrees that it bears the
responsibility to take remedial action in the event of a Board determination of an irreconcilable
material conflict and the cost of such remedial action, and these responsibilities will be carried
out with a view only to the interests of Contract owners.
7.4. If a material irreconcilable conflict arises because of a decision by the Company to
disregard contract owner voting instructions and that decision represents a minority position or
would preclude a majority vote, the Company may be required, at the Fund’s election, to withdraw
the affected Account’s investment in the Fund and terminate this Agreement with respect to such
Account (at the Company’s expense); provided, however that such withdrawal and termination shall be
limited to the extent required by the foregoing material irreconcilable conflict as determined by a
majority of the disinterested members of the Board. No charge or penalty will be imposed as a
result of such withdrawal. The Company agrees that it bears the responsibility to take remedial
action in
the event of a Board determination of an irreconcilable material conflict and the cost of
such remedial action, and these responsibilities will be carried out with a view only to the
interests of Contract owners.
7.5. For purposes of Sections 7.3 and 7.4 of this Agreement, a majority of the disinterested
members of the Board shall determine whether any proposed action adequately remedies any
irreconcilable material conflict, but in no event will the Fund be required to establish a new
funding medium for the Contracts. The Company shall not be required by Section 7.3 or 7.4 to
establish a new funding medium for the Contracts if an offer to do so has been declined by vote of
a majority of Contract owners materially adversely affected by the irreconcilable material
conflict.
7.6. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is
adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated
thereunder with respect to mixed or shared funding (as defined in the Shared Funding Exemptive
Order) on terms and conditions materially different from those contained in the Shared Funding
Exemptive Order, then the Fund and/or the Participating Insurance Companies, as appropriate, shall
take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule
6e-3, as adopted, to the extent such rules are applicable.
7.7 The Company and the Distributor shall at least annually submit to the Board of the Fund
such reports, materials or data as the Board may reasonably request so that the Board may fully
carry out the obligations imposed upon them by the provisions hereof, and said reports, materials
and data shall be submitted more frequently if deemed appropriate by the Board. All reports
received by the Board of potential or existing conflicts, and all Board action with regard to
determining the existence of a conflict, notifying Participating Insurance Companies of a conflict,
and determining whether any proposed action adequately remedies a conflict, shall be properly
recorded in the minutes of the Board or other appropriate records, and such minutes or other
records shall be made available to the SEC upon request.
ARTICLE VIII. Indemnification
8.1. Indemnification By The Company
8.1(a) The Company agrees to indemnify and hold harmless the Fund and each member of its
Board and officers, and the Distributor and each director and officer of the Distributor, and each
person, if any, who controls the Fund or the Distributor within the meaning of Section 15 of
the 1933 Act (collectively, the “Indemnified Parties” and individually, “Indemnified Party,” for
purposes of this Section 8.1) against any and all losses, claims, damages, liabilities (including
amounts paid in settlement with the written consent of the Company) or litigation (including legal
and other expenses), to which the Indemnified Parties may become subject under any statute or
regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or
expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of
the Fund’s shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or
alleged untrue
statements of any material fact contained in the registration statement or
prospectus for the Contracts or contained in the Contracts or sales literature for
the Contracts (or any amendment or supplement to any of the foregoing), or arise out
of or are based upon the omission or the alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, provided that this agreement to indemnify shall not apply as
to any Indemnified Party if such statement or omission or such alleged statement or
omission was made in reliance upon and in conformity with information furnished to
the Company by or on behalf of the Fund for use in the registration statement or
prospectus for the Contracts or in the Contracts or sales literature (or any
amendment or supplement) or otherwise for use in connection with the sale of the
Contracts or Fund shares; or
(ii) arise out of or as a result of any statements or representations (other
than statements or representations contained in the registration statement,
prospectus or sales literature of the Fund not supplied by the Company or persons
under its control and other than statements or representations authorized by the
Fund or the Distributor) or unlawful conduct of the Company or persons under its
control, with respect to the sale or distribution of the Contracts or Fund shares;
or
(iii) arise out of or as a result of any untrue statement or alleged untrue
statement of a material fact contained in a registration statement, prospectus, or
sales literature of the Fund or any amendment thereof or supplement thereto or the
omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading if such a
statement or omission was made in reliance upon and in conformity with information
furnished to the Fund by or on behalf of the Company; or
(iv) arise as a result of any failure by the Company to provide the services
and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation
and/or warranty made by the Company in this Agreement or arise out of or result from
any other material breach of this Agreement by the Company.
8.1(b). Notwithstanding Section 8.1(a) above, the Company shall not be liable under this
indemnification provision with respect to any losses, claims, damages, liabilities or litigation
incurred or assessed against an Indemnified Party as such may arise from such Indemnified Party’s
willful misfeasance, bad faith, or gross negligence in the performance of such Indemnified Party’s
duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under
this Agreement.
8.1(c). Notwithstanding Section 8.1(a) above, the Company shall not be liable under this
indemnification provision with respect to any claim made against an Indemnified Party unless such
Indemnified Party shall have notified the Company in writing within a reasonable time after the
summons or other first legal process giving information of the nature of the claim shall have been
served upon such Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Company of any such claim shall
not relieve the Company from any liability which it may have to the Indemnified Party against whom
such action is brought unless the Company is materially prejudiced by failure to notify. In case
any such action is brought against the Indemnified Parties, the Company shall be entitled to
participate, at its own expense, in the defense of such action. The Company also shall be entitled
to assume the defense thereof, with counsel satisfactory to the party named in the action. After
notice from the Company to such Party of the Company’s election to assume the defense thereof, the
Indemnified Party shall bear the fees and expenses under this Agreement for any legal or other
expenses subsequently incurred by such Party independently in connection with the defense thereof
other than reasonable costs of investigation.
8.1(d). The Indemnified Parties will promptly notify the Company of the commencement of any
litigation or proceedings against them in connection with the issuance or sale of the Fund shares
or the Contracts or the operation of the Fund.
8.2. Indemnification by the Distributor
8.2(a). The Distributor agrees, with respect to each Portfolio that it serves as principal
underwriter, to indemnify and hold harmless the Company and each of its directors and officers and
each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act
(collectively, the “Indemnified Parties” and individually, “Indemnified Party,” for purposes of
this Section 8.2) against any and all losses, claims, damages, liabilities (including amounts paid
in settlement with the written consent of the Distributor) or litigation (including legal and other
expenses) to which the Indemnified Parties may become subject under any statute, at common law or
otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect
thereof) or settlements are related to the operation of the Distributor or the Fund and:
(i) arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained in the registration statement or prospectus
or sales literature of the Fund (or any amendment or supplement to any of the
foregoing), or arise out of or are based upon the omission or the alleged omission
to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading, provided that this agreement to
indemnify shall not apply as to any Indemnified Party if such statement or omission
or such alleged statement or omission was made in reliance upon and in conformity
with information furnished to the Distributor or the Fund by or on behalf of the
Company for use in the registration statement or prospectus for the Fund or in sales
literature (or any amendment or supplement) or otherwise for use in connection with
the sale of the Contracts or Portfolio shares; or
(ii) arise out of or as a result of statements or representations (other than
statements or representations contained in the registration statement, prospectus or
sales literature for the Contracts not supplied by the Distributor or persons under
its control and other than statements or representations authorized by the Company)
or unlawful conduct of the Distributor or persons under its control, with respect to
the sale or distribution of the Contracts or Portfolio shares; or
(iii) arise out of or as a result of any untrue statement or alleged untrue
statement of a material fact contained in a registration statement, prospectus, or
sales literature covering the Contracts, or any amendment thereof or supplement
thereto, or the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statement or statements
therein not misleading, if such statement or omission was made in reliance upon
information furnished in writing to the Company by or on behalf of the Distributor;
or
(iv) arise as a result of any failure by the Distributor to provide the
services and furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation
and/or warranty made by the Distributor in this Agreement or arise out of or result
from any other material breach of this Agreement by the Fund or the Distributor;
including without limitation any failure by the Fund to comply with the conditions
of Article VI hereof.
8.2(b).The Distributor shall not be liable under this indemnification provision with respect
to any losses, claims, damages, liabilities or litigation incurred or assessed against an
Indemnified Party as may arise from such Indemnified Party’s willful misfeasance, bad faith, or
gross negligence in the performance of such Indemnified Party’s duties or by reason of such
Indemnified Party’s reckless disregard of obligations and duties under this Agreement.
8.2(c). The Distributor shall not be liable under this indemnification provision with respect
to any claim made against an Indemnified Party unless such Indemnified Party shall have notified
the Distributor in writing within a reasonable time after the summons or other first legal process
giving information of the nature of the claim shall have been served upon such Indemnified Party
(or after such Indemnified Party shall have received notice of such service on any designated
agent), but
failure to notify the Distributor of any such claim shall not relieve the Distributor from any
liability which it may have to the Indemnified Party against whom such action is brought otherwise
than on account of this indemnification provision. In case any such action is brought against the
Indemnified Parties, the Distributor will be entitled to participate, at its own expense, in the
defense thereof. The Distributor also shall be entitled to assume the defense thereof, with
counsel satisfactory to the party named in the action. After notice from the Distributor to such
Party of the Distributor’s election to assume the defense thereof, the Indemnified Party shall bear
the fees and expenses of any additional counsel retained by it, and the Distributor will not be
liable to such Party under this Agreement for any legal or other expenses subsequently incurred by
such Party independently in connection with the defense thereof other than reasonable costs of
investigation.
8.2(d). The Company agrees promptly to notify the Distributor of the commencement of any
litigation or proceedings against it or any of its officers, trustees or directors in connection
with this
Agreement, the issuance or sale of the Contracts with respect to the operation of each
Account, or the sale or acquisition of shares of the Fund.
8.2(e). It is understood that these indemnities shall have no effect on any other agreement
or arrangement between the Fund and/or its series and the Distributor.
8.3. Indemnification by the Fund
8.3(a). The Fund agrees, with respect to each Portfolio, to indemnify and hold harmless the
Company and each of its directors and officers and each person, if any, who controls the Company
within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” and
individually, “Indemnified Party,” for purposes of this Section 8.3) against any and all losses,
claims, damages, liabilities (including amounts paid in settlement with the written consent of the
Fund) or litigation (including legal and other expenses) to which the Indemnified Parties may
become subject under any statute, at common law or otherwise, insofar as such losses, claims,
damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the
operation of the Fund and:
(i) arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained in the registration statement or prospectus
or sales literature of the Fund (or any amendment or supplement to any of the
foregoing), or arise out of or are based upon the omission or the alleged omission
to state therein a material fact required to be stated therein or necessary to make
the statements therein not misleading, provided that this agreement to indemnify
shall not apply as to any Indemnified Party if such statement or omission or such
alleged statement or omission was made in reliance upon and in conformity with
information furnished to the Fund by or on behalf of the Company for use in the
registration statement or prospectus for the Fund or in sales literature (or any
amendment or supplement) or otherwise for use in connection with the sale of the
Contracts or Portfolio shares; or
(ii) arise out of or as a result of statements or representations (other
than statements or representations contained in the registration statement,
prospectus or sales literature for the Fund not supplied by the Fund or persons
under its control and other than statements or representations authorized by the
Company) or unlawful conduct of the Fund or persons under its control, with respect
to the sale or distribution of the Contracts or Portfolio shares; or
(iii) arise out of or as a result of any untrue statement or alleged untrue
statement of a material fact contained in a registration statement, prospectus, or
sales literature covering the Contracts, or any amendment thereof or supplement
thereto, or the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statement or statements
therein not misleading, if such statement or omission was made in reliance upon
information furnished in writing to the Company by or on behalf of the Fund; or
(iv) arise as a result of any failure by the Fund to provide the services and
furnish the materials under the terms of this Agreement; or
(v) arise out of or result from any material breach of any representation
and/or warranty made by the Fund in this Agreement or arise out of or result from
any other material breach of this Agreement by the Fund; including without
limitation any failure by the Fund to comply with the conditions of Article VI
hereof.
8.2(b).The Fund shall not be liable under this indemnification provision with respect to any
losses, claims, damages, liabilities or litigation incurred or assessed against an Indemnified
Party as may arise from such Indemnified Party’s willful misfeasance, bad faith, or gross
negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified
Party’s reckless disregard of obligations and duties under this Agreement.
8.2(c). The Fund shall not be liable under this indemnification provision with respect to any
claim made against an Indemnified Party unless such Indemnified Party shall have notified the Fund
in writing within a reasonable time after the summons or other first legal process giving
information of the nature of the claim shall have been served upon such Indemnified Party (or after
such Indemnified Party shall have received notice of such service on any designated agent), but
failure to notify the Fund of any such claim shall not relieve the Fund from any liability which it
may have to the Indemnified Party against whom such action is brought otherwise than on account of
this indemnification provision. In case any such action is brought against the Indemnified
Parties, the Fund will be entitled to participate, at its own expense, in the defense thereof. The
Fund also shall be entitled to assume the defense thereof, with counsel satisfactory to the party
named in the action. After notice from the Fund to such Party of the Fund’s election to assume the
defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel
retained by it, and the Fund will not be liable to such Party under this Agreement for any legal or
other expenses subsequently incurred by such Party independently in connection with the defense
thereof other than reasonable costs of investigation.
8.2(d). The Company agrees promptly to notify the Fund of the commencement of any litigation
or proceedings against it or any of its officers, trustees or directors in connection with this
Agreement, the issuance or sale of the Contracts with respect to the operation of each Account, or
the sale or acquisition of shares of the Fund.
8.2(e). It is understood that these indemnities shall have no effect on any other agreement
or arrangement between the Fund and/or its series and the Distributor.
ARTICLE IX. Applicable Law
9.1. This Agreement shall be construed and the provisions hereof interpreted under and in
accordance with the laws of the State of New York.
9.2. This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and
the rules and regulations and rulings thereunder, including such exemptions from those statutes,
rules and regulations as the SEC may grant (including, but not limited to, the Shared Funding
Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE X. Termination
10.1. This Agreement shall continue in full force and effect until the first to occur of:
(a) termination by any party for any reason upon ninety days advance written
notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund and the
Distributor with respect to any Portfolio based upon the Company’s determination
that shares of such Portfolio are not reasonably available to meet the requirements
of the Contracts. Reasonable advance notice of election to terminate shall be
furnished by the Company, said termination to be effective ten (10) days after
receipt of notice unless the Fund makes available a sufficient number of shares to
reasonably meet the requirements of the Account within said ten (10) day period; or
(c) termination by the Company by written notice to the Fund and the
Distributor with respect to any Portfolio in the event any of the Portfolio’s shares
are not registered, issued or sold in accordance with applicable state and/or
federal law or such law precludes the use of such shares as the underlying
investment medium of the Contracts issued or to be issued by the Company. The
terminating party shall give prompt notice to the other parties of its decision to
terminate; or
(d) termination by the Company by written notice to the Fund and the
Distributor with respect to any Portfolio in the event that such Portfolio ceases to
qualify as a Regulated Investment Company under Subchapter M of the Code or
under any successor or similar provision, or if the Company reasonably believes that
the Fund may fail to so qualify; or
(e) termination by the Company by written notice to the Fund and the
Distributor with respect to any Portfolio in the event that such Portfolio fails to
meet the diversification requirements specified in Article VI hereof; or
(f) termination by either the Fund or the Distributor by written notice to the
Company if the Distributor or the Fund shall determine, in its sole judgment
exercised in good faith, that the Company and/or its affiliated companies has
suffered a material adverse change in its business, operations, financial condition
or prospects since the date of this Agreement or is the subject of material adverse
publicity and as a result ability to perform obligations under this Agreement is
materially impaired, provided that the Fund or the Distributor will give the Company
ninety (90) days’ advance written notice of such determination of its intent to
terminate this
Agreement, and provided further that after consideration of the
actions taken by the Company and any other changes in circumstances since the giving
of such notice, the determination of the Fund or the Distributor shall continue to
apply on the 90th day since giving of such notice, then such 90th day shall be the
effective date of termination; or
(g) termination by the Company by written notice to the Fund and the
Distributor, if the Company shall determine, in its sole judgment exercised in good
faith, that either the Fund or the Distributor (with respect to the appropriate
Portfolio) has suffered a material adverse change in its business, operations,
financial condition or prospects since the date of this Agreement or is the subject
of material adverse publicity; provided that the Fund or the Distributor will give
the Company ninety (90) days’ advance written notice of such determination of its
intent to terminate this Agreement, and provided further that after consideration of
the actions taken by the Company and any other changes in circumstances since the
giving of such notice, the determination of the Company shall continue to apply on
the 90th day since giving of such notice, then such 90th day shall be the effective
date of termination; or
(h) termination by the Company in the event that formal administrative
proceedings are instituted against the Fund or Distributor by FINRA, the SEC, or any
state securities or insurance department or any other regulatory body in respect of
the sale of shares of the Fund to the Company, provided, however, that the Company
determines in its sole judgment exercised in good faith, that any such
administrative proceedings will have a material adverse effect upon the ability of
the Fund or the Distributor to perform its obligations under this Agreement; or
(i) termination by the Fund or the Distributor by written notice to the
Company, if the Company gives the Fund and the Distributor the written notice
specified in Section 1.6 hereof and at the time such notice was given there was
no notice of termination outstanding under any other provision of this Agreement;
provided, however any termination under this Section 10.1(h) shall be effective
sixty (60) days after the notice specified in Section 1.6 was given; or
(j) termination by any party upon the other party’s breach of any
representation in Section 2 or any material provision of this Agreement, which
breach has not been cured to the satisfaction of the terminating party within ten
(10) days after written notice of such breach is delivered to the Fund or the
Company, as the case may be; or
(k) termination by the Fund or the Distributor by written notice to the Company
in the event an Account or Contract is not registered or sold in accordance with
applicable federal or state law or regulation, or the Company fails to provide
pass-through voting privileges as specified in Section 3.4; provided that the Fund
or the Distributor will give the Company ninety (90) days’ advance written notice of
such intent.
10.2. Effect of Termination. Notwithstanding any termination of this Agreement, the
Fund shall at the option of the Company, continue to make available additional shares of the Fund
pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the
effective date of termination of this Agreement (hereinafter referred to as “Existing Contracts”)
unless such further sale of Fund shares is proscribed by law, regulation or applicable regulatory
body, or unless the Fund determines that liquidation of the Fund following termination of this
Agreement is in the best interests of the Fund and its shareholders. Specifically, without
limitation, the owners of the Existing Contracts shall be permitted to direct reallocation of
investments in the Fund, redemption of investments in the Fund and/or investment in the Fund upon
the making of additional purchase payments under the Existing Contracts. The parties agree that
this Section 10.2 shall not apply to any terminations under Article VII and the effect of such
Article VII terminations shall be governed by Article VII of this Agreement.
10.3. The Company shall not redeem Fund shares attributable to the Contracts (as distinct
from Fund shares attributable to the Company’s assets held in the Account) except (i) as necessary
to implement Contract Owner initiated or approved transactions, or (ii) as required by state and/or
federal laws or regulations or judicial or other legal precedent of general application
(hereinafter referred to as a “Legally Required Redemption”) or (iii) as permitted by an order of
the SEC pursuant to Section 26(b) of the 1940 Act. Upon request, the Company will promptly furnish
to the Fund the opinion of counsel for the Company (which counsel shall be reasonably satisfactory
to the Fund and the Distributor) to the effect that any redemption pursuant to clause (ii) above is
a Legally Required Redemption. Furthermore, except in cases where permitted under the terms of the
Contracts, the Company shall not prevent Contract Owners from allocating payments to a Portfolio
that was otherwise available under the Contracts without first giving the Fund or the appropriate
Distributor 90 days prior written notice of its intention to do so.
10.4. Notwithstanding any termination of this Agreement pursuant to Article X hereof, all
rights and obligations arising under Article VIII of this Agreement shall survive.
ARTICLE XI. Notices
Any notice shall be sufficiently given when sent by registered or certified mail to the other
party at the address of such party set forth below or at such other address as such party may from
time to time specify in writing to the other party.
If to the Fund:
Royce Capital Fund
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx X. Xxxxxxxxx
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx X. Xxxxxxxxx
If to the Distributor:
Royce Fund Services, Inc.
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx X. Xxxxxxxxx
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx X. Xxxxxxxxx
If to the Company:
Pacific Life & Annuity Company
000 Xxxxxxx Xxxxxx Xxxxx
Xxxxxxx Xxxxx, Xxxxxxxxxx 00000
Attn: General Counsel
000 Xxxxxxx Xxxxxx Xxxxx
Xxxxxxx Xxxxx, Xxxxxxxxxx 00000
Attn: General Counsel
ARTICLE XII. Foreign Tax Credits
The Fund and the Distributor agree to consult with the Company concerning whether any
Portfolio of the Fund qualifies to provide a foreign tax credit pursuant to Section 853 of the
Code.
ARTICLE XIII. Information Sharing
13.1. Company agrees to provide to Distributor or its designee, upon written request, the
taxpayer identification number (“TIN”), if known, of any or all shareholders of the Fund. Company
also agrees to provide the number of shares, dollar value, date, name or other identifier
(including broker identification number) of any investment professional(s) associated with the
shareholder or account (if known), and transaction type (purchase, redemption, transfer or
exchange) of every purchase, redemption, transfer, or exchange of Shares held through an account
maintained by Company during the period covered by the request. Requests must set forth a specific
period, generally not to exceed 90 days from the date of the request, for which transaction
information is sought. Distributor or its designee may request transaction information older than
90 days from the date of the request as it deems necessary to investigate compliance with policies
established by the Fund for the purpose of eliminating or reducing any dilution of the value of the
outstanding shares issued by the Fund.
Company agrees to transmit the requested information that is on its books and records to
Distributor or its designee promptly, but in any event not later than ten (10) business days, or as
otherwise agreed to by the parties, after receipt of a request. If the requested information is
not on the Company’s books and records, Company agrees to (i) provide or arrange to provide to the
Fund the requested information pertaining to shareholders who hold accounts with an indirect
intermediary; or (ii) if directed by Distributor, block further purchases of Shares from such
indirect intermediary. In such instance, Company agrees to inform Distributor whether it plans to
perform (i) or (ii). Responses required by this paragraph must be communicated in writing and in a
format mutually agreed upon by the parties. To the extent practicable, the format for any
transaction information provided to Royce should be consistent with the NSCC Standardized Data
Reporting Format. For purposes of this provision, an “indirect intermediary” has the same meaning
as in SEC Rule 22c-2 under the 0000 Xxx.
13.2. Distributor agrees not to use the information received for marketing or any other
similar purpose without the prior written consent of Company.
13.3. Company agrees to execute written instructions from Distributor to restrict or prohibit
further purchases (including shares acquired by exchanges) of Shares by a shareholder that has been
identified by Distributor or its designee as having engaged in transactions in the Shares (directly
or indirectly through the Company’s account) that violates policies established by the Company.
13.4. Instructions must include the TIN, if known, and the specific restriction(s) to be
executed. If the TIN is not known, the instructions must include an equivalent identifying number
of the shareholder(s) or account(s) or other agreed upon information to which instruction relates.
13.5. Company agrees to execute instruction as soon as practicable, but not later than ten
(10) business days, or as otherwise agreed to by the parties, after receipt of the instructions by
the Company.
13.6. Company must provide written confirmation to Distributor that instructions have been
executed. Company agrees to provide confirmation as soon as reasonably practicable, but not later
than ten (10) business days after the instructions have been executed.
ARTICLE XIV. Miscellaneous
14.1. All persons dealing with the Fund must look solely to the property of the Fund for the
enforcement of any claims against the Fund as neither the Board, officers, agents or shareholders
assume any personal liability for obligations entered into on behalf of the Fund.
14.2. Subject to the requirements of legal process and regulatory authority, each party
hereto shall treat as confidential the names and addresses of the owners of the Contracts and all
information reasonably identified as confidential in writing by any other party hereto and, except
as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses
and other confidential information until such time as it may come into the public domain without
the express written consent of the affected party.
14.3. The captions in this Agreement are included for convenience of reference only and in no
way define or delineate any of the provisions hereof or otherwise affect their construction or
effect.
14.4. This Agreement may be executed simultaneously in two or more counterparts, each of
which taken together shall constitute one and the same instrument.
14.5. If any provision of this Agreement shall be held or made invalid by a court decision,
statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby.
14.6. Each party hereto shall cooperate with each other party and all appropriate
governmental authorities (including without limitation the SEC, FINRA and state insurance
regulators) and shall permit such authorities reasonable access to its books and records in
connection with any investigation or inquiry relating to this Agreement or the transactions
contemplated hereby.
14.7. The rights, remedies and obligations contained in this Agreement are cumulative and are
in addition to any and all rights, remedies and obligations at law or in equity, which the parties
hereto are entitled to under state and federal laws.
14.8. This Agreement or any of the rights and obligations hereunder may not be assigned by
any party without the prior written consent of all parties hereto; provided, however, that the
Distributor may assign this Agreement or any rights or obligations hereunder to any affiliate of or
company under common control with the Distributor, if such assignee is duly licensed and registered
to perform the obligations of the Distributor under this Agreement.
14.9 Upon request by the Fund, the Company shall furnish, or shall cause to be furnished, to
the Fund or its designee copies of the following reports:
(a) the Company’s annual statement (prepared under statutory accounting
principles) and annual report (prepared under generally accepted accounting
principles (“GAAP”), if any),;
(b) the Company’s June 30th quarterly statements (statutory) (and GAAP, if any:
(c) any financial statement, proxy statement, notice or report of the Company
sent to stockholders and/or policyholders;
(d) any registration statement (without exhibits) and financial reports of the
Company filed with the SEC or any state insurance regulator;
(e) any other public report submitted to the Company by independent accountants
in connection with any annual, interim or special audit made by them of the books of
the Company.
14.10. The Company hereby acknowledges that the Fund has notified the Company that it may be
appropriate for its separate account prospectuses or offering memoranda to contain disclosure
regarding the potential risks of mixed and shared funding.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its
name and on its behalf by its duly authorized representative hereto as of the date specified above.
Pacific Life & Annuity Company on behalf of itself and each of its Accounts named in Schedule B
hereto, as amended from time to time.
PACIFIC LIFE & ANNUITY COMPANY
By:
|
ATTEST: |
Name: Xxx X. Xxxxxxxx | Xxxxxx X. Milfs | |||
Title: Assistant Vice President | Corporate Secretary |
ROYCE FUND SERVICES, INC. | ||||
By: |
||||
Title: President | ||||
ROYCE CAPITAL FUND | ||||
By: |
||||
Title: Vice President |
SCHEDULE A
PORTFOLIOS OF ROYCE CAPITAL FUND
FUNDS AVAILABLE FOR PURCHASE BY
Pacific Life & Annuity Company
FUNDS AVAILABLE FOR PURCHASE BY
Pacific Life & Annuity Company
Royce Capital Fund — Micro-Cap Portfolio
SCHEDULE B
SEPARATE ACCOUNTS AND CONTRACTS
PACIFIC LIFE & ANNUITY COMPANY
PACIFIC LIFE & ANNUITY COMPANY
Separate Account
Pacific Select Exec Separate Account
Separate Account I
Separate Account I
Contracts
Pacific Select Exec II-NY
Pacific Select Exec III-NY
Pacific Select Exec IV-NY
Pacific Select Exec V-NY
Pacific Select Estate Preserver-NY
Pacific Select Estate Preserver II
Pacific Select Estate Preserver III
Pacific Select Estate Preserver IV
Pacific Select Estate Preserver V
Pacific Select Estate Preserver VI
Pacific Select Exec III-NY
Pacific Select Exec IV-NY
Pacific Select Exec V-NY
Pacific Select Estate Preserver-NY
Pacific Select Estate Preserver II
Pacific Select Estate Preserver III
Pacific Select Estate Preserver IV
Pacific Select Estate Preserver V
Pacific Select Estate Preserver VI
SCHEDULE C
PROXY VOTING PROCEDURES
The following is a list of procedures and corresponding responsibilities for the handling of
proxies and voting instructions relating to the Fund. The defined terms herein shall have the
meanings assigned in the Participation Agreement except that the term “Company” shall also include
the department or third party assigned by the Company to perform the steps delineated below.
1. | The proxy proposals are given to the Company by the Fund as early as possible before the date set by the Fund for the shareholder meeting to enable the Company to consider and prepare for the solicitation of voting instructions from owners of the Contracts and to facilitate the establishment of tabulation procedures. At this time the Fund will inform the Company of the Record, Mailing and Meeting dates. This will be done verbally approximately two months before meeting. |
2. | Promptly after the Record Date, the Company will perform a “tape run”, or other activity, which will generate the names, addresses and number of units which are attributed to each contract owner/policyholder (the “Customer”) as of the Record Date. Allowance should be made for account adjustments made after this date that could affect the status of the Customers’ accounts as of the Record Date. | |
Note: The number of proxy statements is determined by the activities described in this Step #2. The Company will use its best efforts to call in the number of Customers to the Fund , as soon as possible, but no later than two weeks after the Record Date. |
3. | The text and format for the Voting Instruction Cards (“Cards” or “Card”) is provided to the Company by the Fund. The Fund, at its expense, shall produce and personalize the Voting Instruction Cards. The Company must approve the Card before it is printed. Allow approximately 2-4 business days for printing information on the Cards. Information commonly found on the Cards includes: |
a. | name (legal name as found on account registration) | ||
b. | address | ||
c. | fund or account number | ||
d. | coding to state number of units | ||
e. | individual Card number for use in tracking and verification of votes (already on Cards as printed by the Fund). |
(This and related steps may occur later in the chronological process due to possible uncertainties
relating to the proposals.)
4. | During this time, the Fund will develop, produce and pay for the Notice of Proxy and the Proxy Statement (one document). The Fund shall print and fold notices and statements for insertion into envelopes (envelopes and return envelopes are provided and paid for by the Fund. Contents of envelope sent to Customers by the Fund will include: |
a. | Voting Instruction Card(s) | ||
b. | One proxy notice and statement (one document) | ||
c. | return envelope (postage pre-paid by Company) addressed to the Company or its tabulation agent | ||
d. | “urge buckslip” — optional, but recommended. (This is a small, single sheet of paper that requests Customers to vote as quickly as possible and that their vote is |
important. | One copy will be supplied by the Fund.) |
e. | cover letter — optional, supplied by Fund and reviewed and approved in advance by the Company. |
5. | The above contents should be received by the Company approximately 3-5 business days before mail date. Individual in charge at Company reviews and approves the contents of the mailing package to ensure correctness and completeness. Copy of this approval sent to the Fund. |
6. | Package mailed by the Fund. * |
7. | Collection and tabulation of Cards begins. Tabulation usually takes place in another department or another vendor depending on process used. An often used procedure is to sort Cards on arrival by proposal into vote categories of all yes, no, or mixed replies, and to begin data entry. |
Note: Postmarks are not generally needed. A need for postmark information would be due to an insurance company’s internal procedure and has not been required by the Fund in the past. |
8. | Signatures on Card checked against legal name on account registration which was printed on the Card. |
Note: For example, if the account registration is under “Xxxx X. Xxxxx, Trustee,” then that is the exact legal name to be printed on the Card and is the signature needed on the Card. |
9. | If Cards are mutilated, or for any reason are illegible or are not signed properly, they are sent back to Customer with an explanatory letter and a new Card and return envelope. The mutilated or illegible Card is disregarded and considered to be not received for purposes of vote tabulation. Any Cards that have been “kicked out” (e.g. mutilated, illegible) of the procedure are “hand verified,” i.e., examined as to why they did not complete the system. Any questions on those Cards are usually remedied individually. |
10. | There are various control procedures used to ensure proper tabulation of votes and accuracy of that tabulation. The most prevalent is to sort the Cards as they first arrive into categories depending upon their vote; an estimate of how the vote is progressing may then be calculated. If the initial estimates and the actual vote do not coincide, then an internal audit of that vote should occur. This may entail a recount. |
11. | The actual tabulation of votes is done in units which is then converted to shares. (It is very important that the Fund receives the tabulations stated in terms of a percentage and the number of shares.) The Company must review and approve tabulation format. |
12. | Final tabulation in shares is verbally given by the Fund to the Company prior to the meeting. |
The Fund may request an earlier deadline if reasonable and if required to calculate the vote in time for the meeting. |
13. | A Certification of Mailing and Authorization to Vote Shares will be required from the Company as well as an original copy of the final vote. The Fund will provide a standard form for each Certification. |
14. | The Fund will be required to box and archive the Cards received from the Customers. In the event that any vote is challenged or if otherwise necessary for legal, regulatory, or accounting purposes, the Company will be permitted reasonable access to such Cards. |
15. | All approvals and “signing-off’ may be done orally, but must always be followed up in writing. |